Development and optimization of levodopa and benzylhydrazine orally disintegrating tablets by direct compression and response surface methodology.

AbstractThe number of Parkinson's disease (PD) patients with the advanced phase and motor fluctuations is increasing. The objective of this study is developing levodopa/benzylhydrazine orally disin...